WALTHAM, MA — January 9, 2023 — CorEvitas, LLC, the leading sponsor of syndicated clinical registries in autoimmune and inflammatory diseases, has launched and is recruiting patients in a first-of-its-kind registry to evaluate the safety and effectiveness of newly approved therapies for patients...Learn More
News
Jan 9 2023 - 7:00am
News
Nov 21 2022 - 12:00pm
Investment augments CorEvitas’ pharmacovigilance services to fulfill global regulatory requirements for the safety of medications and vaccines during pregnancy
Waltham, MA and Los Angeles, CA, November 22, 2022 – CorEvitas, LLC (“CorEvitas”), an industry leader in syndicated registries,...Learn More
News
Jul 6 2022 - 6:00am
Waltham, MA and London, UK, July 6, 2022 — CorEvitas, LLC is excited to announce expanded services to include specialty EMR data through its Specialty EMR Data Business Unit. Health iQ Limited, a subsidiary of CorEvitas, has provided innovative real-world evidence solutions in...Learn More
News
May 11 2022 - 7:00am
Panelists explore how connecting claims and clinical registry data lead to a better understanding of the patient journey
Waltham, MA and Bowie, MD, May 11, 2022—CorEvitas, LLC, the built-for-purpose provider of real-world evidence, and Inovalon, a leading...Learn More